The Allergy Treatment Market covers products that provide relief from symptoms of allergies such as antihistamines, corticosteroids, decongestants and mast cell stabilizers. Allergies are hypersensitivity reactions to foreign substances known as allergens such as dust mites, pollen, pet dander, cockroaches etc. that trigger an immune response in the body. Rising environmental pollution and changing climate have increased exposure to various allergens and the prevalence of allergic diseases like asthma, allergic rhinitis, atopic dermatitis and food allergies. Oral antihistamines are the most common and effective drugs for treating symptoms like sneezing, itching, rash and congestion. With growing awareness about available treatment options, the demand for these drugs is rising globally.

The global allergy treatment market is estimated to be valued at USD 21.19 Bn in 2024 and is expected to reach USD 34.42 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

Key Takeaways

Key players operating in the Allergy Treatment are Sanofi, Novartis, GSK plc, Johnson and JohnsonServices, Inc., F. Hoffmann-La Roche Ltd., Stallergenes Greer, Dermapharm Holding SE, Nicox, Allergy Therapeutics, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, ALK-Abelló A/S, Bausch Health Companies Inc., GLENMARK PHARMACEUTICALS LTD., Perrigo Company plc, and Dr Reddy's Laboratories Ltd. They invest heavily in R&D to develop newer drugs and devices for Allergy Treatment Market Growth. The growing prevalence of allergic diseases like asthma and rhinitis globally is driving the demand for allergy medicines.

Get More Insights on- Allergy Treatment Market